Working paper 72: Analysis of Individual Income Protection Experience, 1991-2009, by Cause of Sickness

The 73 individual causes of sickness recorded in the data have been grouped into 15 ‘medically similar’ cause of sickness groups. The analysis of claim inceptions investigates which causes of sickness are most significant by age, sex, deferred period, occupation class and over time. The analysis of claimant recoveries shows that there are marked differences between the overall claim terminations experience of different cause groups which cannot be explained by variations in other rating factors.

The paper includes two separate further analyses that are linked to the analysis of claim inceptions. An analysis of cause of sickness by matched duration considers how the distribution of cause of sickness varies by deferred period. A preliminary analysis of the distribution of claim cost by cause of sickness builds on previous work to demonstrate the disparity between the distributions of claim incidence and claim cost by cause of sickness.

The paper also reviews previous research that has been carried out on this topic.

The accompanying spreadsheet contains two databases, covering inceptions and terminations experience, to enable practitioners to pursue further investigations.

Documents

You might also like

Contact Details

If you have any questions about the CMI please email

info@cmilimited.co.uk

Filter or search events

Start date
E.g., 04/03/2021
End date
E.g., 04/03/2021

Events calendar

  • Finance in the Public Interest Series

    16 March 2021 - 23 March 2021

    Spaces available

    There is widening debate that many of our social, financial and regulatory institutions need to be rethought so that we can create more sustainable futures, particularly in light of the Covid-19 pandemic, the policy/macro-economic response to the pandemic and how it affects consumers, as well as the impending climate crisis. This multi-day series of three keynote webinars, individually presented by leading economist John Kay, Sir Paul Collier, Professor of Economics and Public Policy at the Blavatnik School of Government, Ashok Gupta, Chair at Mercer Ltd, and Nico Aspinall, Chief Investment Officer at B&CE, will open up discussion on these essential topics. The series will culminate in a panel session with Chief Economist of the Bank of England, Andy Haldane.

  • The price is righter

    16 March 2021

    Spaces available

    This webinar provides an overview of the state of the UK protection market, and how different insurers are using different levels of sophistication to price (such as using customer demand models). It considers how insurers have implemented these sophisticated pricing techniques, and the practical challenges they have faced.

  • Spaces available

    This discussion will revolve around the latest industry developments including and introduction to Part VII transfers and Schemes of Arrangement (process, parties involved and recent events), insights and lessons from recent with-profits transactions and restructurings (including Equitable Life and Pru-Rothesay), how firms can apply these learnings to future arrangements, and the outlook for future with-profits transactions and restructurings (including the impacts of Covid-19 and Brexit)

     

  • Spaces available

    What is stewardship and how has the landscape changed under the 2020 UK Stewardship Code? How does effective stewardship create long term value for beneficiaries and what roles do asset owners and asset managers play in active stewardship. This webinar will offer answers to these questions in a practical approach to stewardship reporting.

  • Spaces available

    Mis-estimation risk is a key element of demographic risk, and past work has focused on mis-estimation risk on a run-off basis.  However, this does not meet the requirements of regulatory regimes like Solvency II, which demands that capital requirements are set through the prism of a finite horizon like one year.  This paper presents a value-at-risk approach to mis-estimation risk suitable for Solvency II work.